News search

A new analysis of the DapaTAVI trial, published in the European Journal of Heart Failure, confirms that dapagliflozin improves outcomes after TAVI regardless of cardiac function.

The research, presented in a Hot Line session at the European Society of Cardiology Congress in Munich and published simultaneously in The New England Journal of Medicine, proposes a paradigm shift towards prevention based on early detection through vascular imaging

The protein, OMA1, delays immune-system overactivation, liver fibrosis, and liver cancer during aging

Left ventricular hypertrabeculation, an anatomical feature of the heart traditionally linked to higher risk, does not worsen outcomes in patients with dilated cardiomyopathy

The findings suggest that a risk-based personalized approach may be more efficient than applying intensive surveillance protocols uniformly to all patients. 

The Foundation recognises the pioneering research into the link between gut microbiota and cardiovascular disease led by David Sancho at the CNIC 

The young Lithuanian researcher was recognised for a project on new molecular targets for the antiviral treatment of intestinal infections